Open AccessPOOLED ANALYSIS OF PHASE III STUDIES OF ZENAPAX?? (DACLIZUMAB), A HUMANIZED ANTI-IL-2R ANTIBODY
Author(s) -
Zenapax Double and Triple Therapy Study Groups
Publication year - 1998
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-199806270-00731
Subject(s) - daclizumab , medicine , placebo , azathioprine , transplantation , gastroenterology , cumulative incidence , incidence (geometry) , acute tubular necrosis , adverse effect , kidney transplantation , urology , surgery , immunology , kidney , tacrolimus , pathology , alternative medicine , physics , disease , optics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom